Expression and Clinical Significance of miR-146a and Tumor Necrosis Factor Receptor-Associated Factor 6 (TRAF6) in Myasthenia Gravis Patient Serum
- Type
- Retraction
- Notice date
- 1/9/2024 0:00
- Journal
- BioMed Research International
- Publisher
- Hindawi
- Notice DOI
- 10.1155/2024/9754648
- Original paper DOI
- 10.1155/2021/5573469
Reasons
- Compromised Peer Review
- Investigation by Journal/Publisher
- Investigation by Third Party
- Paper Mill
- Unreliable Results and/or Conclusions